Pei-Jean Feng - Concepedia

Author

Pei-Jean Feng

Centers for Disease Control and Prevention

Also Known As

Pei-Jean Feng, Pei-Jean I Feng, Pei-Jean I. Feng

Publications

704

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention Denver Health Medical Center University of Colorado Denver Duke Medical Center California Department of Public Health

About

Pei-Jean Feng is an author at Centers for Disease Control and Prevention specializing in tuberculosis, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	198
2	Public Health	3	3	143
3	Epidemiology	3	3	143
4	Global Health	1	1	62
5	International Health	1	1	62

Pei-Jean Feng

Publications

692

Citations

H-Index

Page 1

	Year	Citations
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection Robert Belknap, David P. Holland, Pei-Jean Feng, Annals of Internal Medicine	2017	166
Tuberculosis — United States, 2023 Paula M. Williams, Robert Pratt, William L. Walker, MMWR Morbidity and Mortality Weekly Report	2024	101
Sustained Reduction in the Clinical Incidence of Methicillin-Resistant <i>Staphylococcus aureus</i> Colonization or Infection Associated with a Multifaceted Infection Control Intervention Katherine Ellingson, Robert R. Muder, Rajiv Jain, Infection Control and Hospital Epidemiology	2010	76
Evaluating latent tuberculosis infection diagnostics using latent class analysis Jason E. Stout, Yanjue Wu, Christine Ho, Thorax	2018	64
Tuberculosis — United States, 2021 Thomas D. Filardo, Pei-Jean Feng, Robert Pratt, MMWR Morbidity and Mortality Weekly Report Tuberculosis PreventionPopulation Health SciencesUnited StatesCovid-19Clinical Epidemiology	2022	62
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova, Contemporary Clinical Trials Pulmonary TuberculosisHigh-dose RifapentineMedicineTbtc Study 31/ActgTuberculosis	2020	55
Tuberculosis — United States, 2022 Kimberly R. Schildknecht, Robert Pratt, Pei-Jean Feng, MMWR Morbidity and Mortality Weekly Report Tb EpidemiologyTuberculosis PreventionEpidemiologic ResearchPopulation Health SciencesClinical Epidemiology	2023	48
Interferon-γ Release Assays in Children &lt;15 Years of Age Amina Ahmed, Pei-Jean Feng, James Gaensbauer, PEDIATRICS	2019	45
Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study Christine Ho, Pei-Jean Feng, Masahiro Narita, The Lancet Infectious Diseases Epidemiological TrendPulmonary TuberculosisHigh-risk PeopleEpidemiological OutcomeLatent Tuberculosis Infection	2021	33
Incidence and Clinical Characteristics of and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Pregnant Individuals in the United States Fatimah S. Dawood, Michael W. Varner, Alan Tita, Clinical Infectious Diseases	2021	22

Page 1